Global X Genomics & Biotechnology ETF
GNOM
GNOM
42 hedge funds and large institutions have $11.7M invested in Global X Genomics & Biotechnology ETF in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
62% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 13
Holders
42
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$269K | |
| 2 | +$236K | |
| 3 | +$206K | |
| 4 |
SEI Investments
Oaks,
Pennsylvania
|
+$135K |
| 5 |
Rockefeller Capital Management
New York
|
+$121K |
Top Sellers
| 1 | -$956K | |
| 2 | -$533K | |
| 3 | -$432K | |
| 4 |
OCM
One Capital Management
Westlake Village,
California
|
-$255K |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$198K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AAS
51
Ameritas Advisory Services
Lincoln,
Nebraska
| – |
|
|||
|
EDRH
52
Edmond de Rothschild Holding
Chambesy,
Switzerland
| – |
|
|||
|
T
53
Transce3nd
Kyle,
Texas
| – |
|
|||
|
SS
54
Sunbelt Securities
Houston,
Texas
| – |
|
|||
|
BBPWM
55
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
| – |
|
|||
56
JP Morgan Chase
New York
| – |
|